Clinical Trial

Digital Mindfulness Meditation in Adolescents With Atopic Dermatitis

Study acronym: MIND-AD
Recruiting
View on ClinicalTrials.gov →
Summary
Atopic dermatitis is well reported to have a significant impact on well-being in adolescents with atopic dermatitis, without clear recommendations for intervention. The investigators aim to identify an accessible, effective digital health intervention for these patients. The investigators hypothesize that regular use of a digital mindfulness meditation app will improve disease control and quality of life in adolescents with moderate to severe atopic dermatitis based on validated survey measures.
Trial Details
NCT Number NCT07746427
Lead Sponsor Weill Medical College of Cornell University
Collaborators: Columbia University
Conditions Atopic Dermatitis, Eczema
Enrollment 40 participants
Start Date 2026-08-15
Primary Completion 2028-07 (estimated)
Study Completion 2028-07 (estimated)
Updated on ClinicalTrials.gov 2026-08-07